DNA demethylation in PD-1 gene promoter induced by 5-azacytidine activates PD-1 expression on Molt-4 cells

Cellular Immunology

Volumn 271, Issue 2, 2011, Pages 450-454

  Zhang, Min ^a   Xiao, Xin Q ^a   Jiang, Yong F ^a   Liang, Yun S ^a   Peng, Min Y ^b   Xu, Yun ^a   Gong, Guo Z ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

5 Azacytidine; Molt 4 cells; PD 1 expression; PD 1 gene promoter demethylation

Indexed keywords

AZACITIDINE; MESSENGER RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN MOLT 4; DNA METHYLATION; FLOW CYTOMETRY; GENE; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; LYMPHOID CELL LINE; PRIORITY JOURNAL; PROGRAMMED DEATH 1 GENE; PROGRAMMED DEATH 1 GENE PROMOTER; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION;

APOPTOSIS; AZACITIDINE; BASE SEQUENCE; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DNA PRIMERS; DNA, NEOPLASM; GENE EXPRESSION; HUMANS; PROGRAMMED CELL DEATH 1 RECEPTOR; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; RNA, NEOPLASM;

EID: 80054038985     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.08.014     Document Type: Article

References (27)

1. Ishida Y., Agata Y., Shibahara K. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992, 11:3887-3895.
2. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T cell immunity. Nat. Rev. Immunol. 2004, 4:336-347.
3. Loke P., Allison J.P. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. PNAS 2003, 100:5336-5341.
4. Sheppard K.A., Fitz L.J., Lee J.M., Benander C., George J.A., Wooters J., Qiu Y., Jussif J.M., Carter L.L., Wood C.R., Chaudhary D. PD-1inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS Lett. 2004, 574:37-41.
5. Loke P., Allison J.P. Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells. Arthritis Res. Ther. 2004, 6:208-214.
6. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439:682-687.
7. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., Mackey E.W., Miller J.D., Leslie A.J., DePierres C., Mncube Z., Duraiswamy J., Zhu B., Eichbaum Q., Altfeld M., Wherry E.J., Coovadia H.M., Goulder P.J., Klenerman P., Ahmed R., Freeman G.J., Walker B.D. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443:350-354.
8. Petrovas C., Casazza J.P., Brenchley J.M., Price D.A., Gostick E., Adams W.C., Precopio M.L., Schacker T., Roederer M., Douek D.C., Koup R.A. PD-1 is a regulator of virus specific CD8+ T cell survival in HIV infection. J. Exp. Med. 2006, 203:2281-2292.
9. Urbani S., Amadei B., Tola D., Massari M., Schivazappa S., Missale G., Ferrari C. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. 2006, 80:11398-11403.
10. Ha S.J., Mueller S.N., Wherry E.J., Barber D.L., Aubert R.D., Sharpe A.H., Freeman G.J., Ahmed R. Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J. Exp. Med. 2008, 205:543-555.
11. Evans A., Riva A., Cooksley H., Phillips S., Puranik S., Nathwani A., Brett S., Chokshi S., Naoumov N.V. Programmed death 1 expression during antiviral treatment of chronic hepatitis B: impact of hepatitis B e-antigen seroconversion. Hepatology 2008, 48:759-769.
12. Watanabe T., Bertoletti A., Tanoto T.A. PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection. J. Viral Hepat. 2010, 17:453-458.
13. Kilberg M.S. Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells. Biochem. J. 2001, 357:321-328.
14. Mossman D., Kim K.T., Scott R.J. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. BMC Cancer 2010, 12:10-366.
15. Luo Y., Li Y., Su Y., Yin H., Hu N., Wang S., Lu Q. Abnormal DNA methylation in T cells from patients with subacute cutaneous lupus erythematosus. Br. J. Dermatol. 2008, 159:827-833.
16. Loke P., Allison J.P. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. PNAS 2003, 100:5336-5341.
17. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439:682-687.
18. Petrovas C., Casazza J.P., Brenchley J.M., Price D.A., Gostick E., Adams W.C., Precopio M.L., Schacker T., Roederer M., Douek D.C., Koup R.A. PD-1 is a regulator of virus specific CD8+ T cell survival in HIV infection. J. Exp. Med. 2006, 203:2281-2292.
19. Xie D.Y., Lin B.L., Chen F.J., Deng H., Chong Y.T., Zhang X.H., Gao Z.L. Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2010, 18:646-650.
20. Li J., Chen F., Zheng M., Zhu H., Zhao D., Liu W., Liu W., Chen Z. Inhibition of STAT1 methylation is involved in the resistance of hepatitis B virus to Interferon alpha. Antiviral Res. 2010, 85:463-469.
21. Szyf M., Pakneshan P., Rabbani S.A. DNA demethylation and cancer: therapeutic implications. Cancer Lett. 2004, 10:133-143.
22. Richardson B., Ray D., Yung R. Murine models of lupus induced by hypomethylated T cells. Methods Mol. Med. 2004, 102:285-294.
23. Quddus J., Johnson K.J., Gavalchin J., Amento E.P., Chrisp C.E., Yung R.L., Richardson B.C. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors is sufficient to cause a lupus-like disease in syngeneic mice. J. Clin. Invest. 1993, 92:38-53.
24. Kaplan M.J., Lu Q., Wu A., Attwood J., Richardson B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J. Immunol. 2004, 172:3652-3661.
25. Lu Q., Kaplan M., Ray D., Zacharek S., Gutsch D., Richardson B. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum. 2002, 46:1282-1291.
26. Aguilera O., Fernández A.F., Muñoz A., Fraga M.F. Epigenetics and environment: a complex relationship. J. Appl. Physiol. 2010, 109:243-251.
27. Smit D.J., Smith A.G., Parsons P.G., Muscat G.E., Sturm R.A. Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors. Eur. J. Biochem. 2000, 267:6413-6422.